XML 37 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details 2) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Jul. 27, 2014
Jul. 28, 2013
Jul. 27, 2014
Jul. 28, 2013
Stock-based compensation expense, along with the related income tax benefit        
Stock based compensation expense recognized $ 1,746,000 $ 4,523,000 $ 12,690,000 $ 16,429,000
Income tax benefit recognized (663,000) (1,710,000) (4,822,000) (6,212,000)
After-tax stock-based compensation expense 1,083,000 2,813,000 7,868,000 10,217,000
Stock-based compensation expense unrecognized 9,600,000   9,600,000  
Period for recognition of unrecognized stock-based compensation expense     2 years 8 months 12 days  
Stock options
       
Stock-based compensation        
Cash received from stock options exercised 3,000,000 700,000 8,500,000 29,300,000
Tax benefit realized from stock options, aggregate 8,900,000 1,000,000 21,000,000 24,700,000
Reconciliation of Stock Options        
Outstanding, at the beginning of the period (in shares)     18,466  
Granted (in shares)     1,400  
Exercised (in shares)     1,860  
Forfeited (in shares)     17  
Outstanding, at the end of the period (in shares) 17,989   17,989  
Exercisable at the end of the period (in shares) 13,031   13,031  
Weighted-Average Exercise Price        
Outstanding at the beginning of the period (in dollars per share)     $ 22.09  
Granted (in dollars per share)     $ 45.43  
Exercised (in dollars per share)     $ 17.48  
Forfeited (in dollars per share)     $ 32.56  
Outstanding at the end of the period (in dollars per share) $ 24.37   $ 24.37  
Exercisable at end of period (in dollars per share) $ 20.61   $ 20.61  
Weighted-Average Remaining Contractual Term        
Outstanding at the end of the period     5 years 6 months  
Exercisable at end of period     4 years 4 months 24 days  
Aggregate Intrinsic Value        
Outstanding at the end of the period 419,989,000   419,989,000  
Exercisable at end of period 353,319,000   353,319,000  
Weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised        
Weighted-average grant date fair value of options granted (in dollars per share) $ 10.52 $ 7.75 $ 9.70 $ 5.50
Intrinsic value of exercised options 23,512,000 2,591,000 55,481,000 65,244,000
Weighted-average assumptions used to calculate fair value of each ordinary option award        
Risk-Free Interest Rate (as a percent) 2.60% 1.40% 2.50% 1.40%
Dividend Yield (as a percent) 1.70% 1.70% 1.80% 2.10%
Stock Price Volatility (as a percent) 20.00% 20.00% 20.00% 20.00%
Expected Option Life 8 years 8 years 8 years 8 years
Nonvested shares
       
Reconciliation of the nonvested shares        
Nonvested shares at the beginning of the period     112  
Nonvested shares granted in period     33  
Nonvested shares vested in period     75  
Nonvested shares forfeited in period     5  
Nonvested shares at the end of the period 65   65  
Weighted-average grant date fair value and total fair value of nonvested shares granted, vested and forfeited        
Nonvested shares at the beginning of the period (in dollars per share)     $ 24.77  
Nonvested shares granted in period (in dollars per share)     $ 43.46 $ 35.42
Nonvested shares vested in period (in dollars per share)     $ 27.35  
Nonvested shares forfeited in period (in dollars per share)     $ 19.56  
Nonvested shares at the end of the period (in dollars per share) $ 31.74   $ 31.74  
Fair value of nonvested shares granted     1,440,000 1,600,000
Fair value of shares vested     $ 2,056,000 $ 1,758,000